Chemomab Therapeutics Ltd. (CMMB)
1.75
-0.11
(-5.91%)
USD |
NASDAQ |
Jun 02, 16:00
1.75
0.00 (0.00%)
After-Hours: 20:00
Chemomab Therapeutics EPS Diluted (Quarterly) : -0.2218 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLineRx Ltd. | -0.5804 |
| Kamada Ltd. | 0.0716 |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | -0.7321 |
| Entera Bio Ltd. | -0.0734 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.768M |
| Total Expenses (Quarterly) | 1.768M |
| Enterprise Value | 5.350M |
| Earnings Yield | -63.31% |
| Normalized Earnings Yield | -63.33 |